142280 — Green Cross Medical Science Balance Sheet
0.000.00%
- KR₩87bn
- KR₩108bn
- KR₩104bn
- 50
- 32
- 26
- 25
Annual balance sheet for Green Cross Medical Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,503 | 1,843 | 10,751 | 5,744 | 678 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29,492 | 21,623 | 20,807 | 21,364 | 17,858 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 61,489 | 52,351 | 50,137 | 43,345 | 39,429 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 40,115 | 40,013 | 41,158 | 42,850 | 45,054 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 105,603 | 95,629 | 96,471 | 90,529 | 87,975 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 39,097 | 48,870 | 39,488 | 46,528 | 37,123 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 49,136 | 59,514 | 63,216 | 56,030 | 46,760 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 56,466 | 36,115 | 33,255 | 34,499 | 41,214 |
Total Liabilities & Shareholders' Equity | 105,603 | 95,629 | 96,471 | 90,529 | 87,975 |
Total Common Shares Outstanding |